|
Biomolecular Modeling Database (BMOD) |
|
BMOD preprocessed databases
Release 3 (24 Sept. 2018):
Release 2 (24 April 2018):
Database |
Description/type |
Num. Compounds |
Processed entries |
BMRB |
Metabolites |
1067 |
|
Chiral drug |
Drugs |
50 |
|
MassBank |
Small molecules |
43595 |
|
Maybridge |
Ro3 Diversity Fragment Library |
964 |
|
NCATS |
MIPE |
400 |
|
NCI |
Natural Products Set IV |
419 |
|
NCI |
AIDS Antiviral Screen Data |
43200 |
|
NCI |
Diversity Set V |
1593 |
|
NCI |
Approved Oncology Drugs Set VIII |
91 |
|
NCI |
Mechanistic Set III |
804 |
|
PDB |
Ligand Expo |
26450 |
|
Selleckchem |
Natural product library |
172 |
|
Selleckchem |
Antidiabetic compound library |
33 |
|
Selleckchem |
Cambridge cancer compound list |
264 |
|
Selleckchem |
MAPK inhibitor library |
61 |
|
Selleckchem |
Anti cancer compound library |
914 |
|
Selleckchem |
FDA Drug list |
1443 |
|
StreptomeDB |
Natural product |
2823 |
|
Universal Natural Product Database |
Natural product |
229,260 |
|
Total |
|
353,603 |
Release 1 (12 Jan 2018):
-
BMRB: Metabolites from Biological Magnetic Resonance Database.
Processed data entries:
-
Maybridge: The Maybridge Ro3 Diversity Fragment Library (the core set of 1000 molecular fragments).
Processed data entires:
-
National Cancer Institute (NCI) compound sets:
- Diversity Set V:
- Mechanistic Set III:
- Approved Oncology Drugs Set VIII:
- Natural Products Set IV:
-
SelleckChem screening libraries:
- Anti-cancer Compound Library:
- Anti-diabetic Compound Library:
- Cambridge Cancer Compound Library:
- FDA-approved Drug Library:
- MAPK Inhibitor Library:
- Natural Product Library:
-
StreptomeDB: Natural products from StreptomeDB 2.0
Processed data entries:
|
|
|